HEADER TRANSFERASE 19-NOV-13 4CFU TITLE STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6-CYCLOHEXYLMETHOXYGUANINE TITLE 2 CDK1 AND 2 INHIBITORS. COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLIN-DEPENDENT KINASE 2; COMPND 3 CHAIN: A, C; COMPND 4 SYNONYM: CELL DIVISION PROTEIN KINASE 2, P33 PROTEIN KINASE; COMPND 5 EC: 2.7.11.22, 2.7.11.23; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: PHOSPHORYLATED ON RESIDUE T160; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: CYCLIN-A2; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: CDK-ACTIVATING FRAGMENT, RESIDUES 172-432; COMPND 12 SYNONYM: CYCLIN-A; COMPND 13 ENGINEERED: YES; COMPND 14 MOL_ID: 3; COMPND 15 MOLECULE: CYCLIN-A2; COMPND 16 CHAIN: D; COMPND 17 FRAGMENT: CDK-ACTIVATING FRAGMENT, RESIDUES 172-432; COMPND 18 SYNONYM: CYCLIN-A; COMPND 19 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI B; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 37762; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: 834; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PGEX-6P-1; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI B; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 37762; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: 834; SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PET21D; SOURCE 19 MOL_ID: 3; SOURCE 20 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 21 ORGANISM_COMMON: HUMAN; SOURCE 22 ORGANISM_TAXID: 9606; SOURCE 23 EXPRESSION_SYSTEM: ESCHERICHIA COLI B; SOURCE 24 EXPRESSION_SYSTEM_TAXID: 37762; SOURCE 25 EXPRESSION_SYSTEM_STRAIN: 834; SOURCE 26 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 27 EXPRESSION_SYSTEM_PLASMID: PET21D KEYWDS TRANSFERASE, STRUCTURE-BASED DRUG DESIGN, CONFORMATIONAL RESTRAINT, KEYWDS 2 REVERSED BINDING MODE EXPDTA X-RAY DIFFRACTION AUTHOR B.CARBAIN,D.J.PATERSON,E.ANSCOMBE,A.CAMPBELL,C.CANO,A.ECHALIER, AUTHOR 2 J.ENDICOTT,B.T.GOLDING,K.HAGGERTY,I.R.HARDCASTLE,P.JEWSBURY, AUTHOR 3 D.R.NEWELL,M.E.M.NOBLE,C.ROCHE,L.Z.WANG,R.GRIFFIN REVDAT 3 23-OCT-24 4CFU 1 REMARK REVDAT 2 20-DEC-23 4CFU 1 REMARK LINK REVDAT 1 10-DEC-14 4CFU 0 JRNL AUTH B.CARBAIN,D.J.PATERSON,E.ANSCOMBE,A.CAMPBELL-DEXTER,C.CANO, JRNL AUTH 2 A.ECHALIER,J.ENDICOTT,B.T.GOLDING,K.HAGGERTY,I.R.HARDCASTLE, JRNL AUTH 3 P.J.JEWSBURY,D.R.NEWELL,M.NOBLE,C.ROCHE,L.WANG,R.J.GRIFFIN JRNL TITL 8-SUBSTITUTED O6-CYCLOHEXYLMETHYLGUANINE CDK2 INHIBITORS; JRNL TITL 2 USING STRUCTURE-BASED INHIBITOR DESIGN TO OPTIMISE AN JRNL TITL 3 ALTERNATIVE BINDING MODE. JRNL REF J.MED.CHEM. V. 57 56 2014 JRNL REFN ISSN 0022-2623 JRNL PMID 24304238 JRNL DOI 10.1021/JM401555V REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0049 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.82 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 70608 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.184 REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.221 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3750 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 5116 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.91 REMARK 3 BIN R VALUE (WORKING SET) : 0.2540 REMARK 3 BIN FREE R VALUE SET COUNT : 279 REMARK 3 BIN FREE R VALUE : 0.2960 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8819 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 489 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.76 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.91000 REMARK 3 B22 (A**2) : 0.81000 REMARK 3 B33 (A**2) : 0.10000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.219 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.181 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.138 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.845 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.953 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.934 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 9202 ; 0.018 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 8965 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 12517 ; 1.926 ; 1.985 REMARK 3 BOND ANGLES OTHERS (DEGREES): 20674 ; 2.464 ; 3.002 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1119 ; 6.282 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 402 ;40.456 ;24.005 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1617 ;16.900 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 47 ;20.703 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1413 ; 0.125 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 10179 ; 0.009 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 2064 ; 0.010 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 4422 ; 0.962 ; 1.695 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 4421 ; 0.960 ; 1.695 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5529 ; 1.435 ; 2.536 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 4780 ; 1.232 ; 1.848 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A -3 A 298 REMARK 3 ORIGIN FOR THE GROUP (A): -6.8820 26.1200 -10.1960 REMARK 3 T TENSOR REMARK 3 T11: 0.0339 T22: 0.0382 REMARK 3 T33: 0.0405 T12: 0.0104 REMARK 3 T13: 0.0255 T23: -0.0178 REMARK 3 L TENSOR REMARK 3 L11: 1.8543 L22: 0.9955 REMARK 3 L33: 1.8704 L12: 0.4495 REMARK 3 L13: 0.9062 L23: 0.2145 REMARK 3 S TENSOR REMARK 3 S11: 0.0168 S12: 0.0549 S13: -0.0320 REMARK 3 S21: -0.1169 S22: 0.0286 S23: -0.1340 REMARK 3 S31: 0.0957 S32: 0.1211 S33: -0.0453 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 171 B 432 REMARK 3 ORIGIN FOR THE GROUP (A): -21.1850 -0.4530 3.1690 REMARK 3 T TENSOR REMARK 3 T11: 0.1112 T22: 0.0797 REMARK 3 T33: 0.0530 T12: -0.0173 REMARK 3 T13: -0.0488 T23: 0.0547 REMARK 3 L TENSOR REMARK 3 L11: 1.3030 L22: 2.0827 REMARK 3 L33: 1.9545 L12: -0.2236 REMARK 3 L13: -0.4847 L23: 0.4662 REMARK 3 S TENSOR REMARK 3 S11: -0.0140 S12: -0.1932 S13: -0.1124 REMARK 3 S21: 0.0544 S22: 0.0725 S23: -0.0021 REMARK 3 S31: 0.3073 S32: 0.0063 S33: -0.0585 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C -2 C 296 REMARK 3 ORIGIN FOR THE GROUP (A): -43.8890 -15.0520 -30.8680 REMARK 3 T TENSOR REMARK 3 T11: 0.2442 T22: 0.0623 REMARK 3 T33: 0.0956 T12: -0.0187 REMARK 3 T13: 0.0519 T23: -0.0425 REMARK 3 L TENSOR REMARK 3 L11: 1.4743 L22: 2.3192 REMARK 3 L33: 1.5196 L12: 0.5375 REMARK 3 L13: 0.7257 L23: 0.2284 REMARK 3 S TENSOR REMARK 3 S11: 0.0894 S12: 0.0440 S13: -0.0515 REMARK 3 S21: 0.1201 S22: -0.0853 S23: 0.1309 REMARK 3 S31: 0.1872 S32: -0.0940 S33: -0.0040 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : D 171 D 432 REMARK 3 ORIGIN FOR THE GROUP (A): -45.3330 17.7850 -33.3150 REMARK 3 T TENSOR REMARK 3 T11: 0.1696 T22: 0.0735 REMARK 3 T33: 0.2259 T12: 0.0724 REMARK 3 T13: -0.0081 T23: -0.0592 REMARK 3 L TENSOR REMARK 3 L11: 2.5327 L22: 3.1798 REMARK 3 L33: 1.6462 L12: 0.3956 REMARK 3 L13: -0.3947 L23: 0.4697 REMARK 3 S TENSOR REMARK 3 S11: -0.0324 S12: 0.0214 S13: 0.3234 REMARK 3 S21: 0.0456 S22: -0.1154 S23: 0.7403 REMARK 3 S31: -0.1765 S32: -0.2657 S33: 0.1478 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 4CFU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-NOV-13. REMARK 100 THE DEPOSITION ID IS D_1290059023. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ELETTRA REMARK 200 BEAMLINE : 5.2R REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX SX-165MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 74525 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 19.800 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 3.240 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.36000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1H1S REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.82 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50 MM AMMONIUM ACETATE, 10% PEG-3350, REMARK 280 15 MM NACL, 100 MM HEPES, PH = 7.4, 10% DMSO REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.90300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 73.73000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 66.87200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 73.73000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.90300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 66.87200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4510 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23270 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.1 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4520 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22600 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -4 REMARK 465 THR A 39 REMARK 465 GLU A 40 REMARK 465 GLY C -4 REMARK 465 PRO C -3 REMARK 465 PRO C 222 REMARK 465 ASP C 223 REMARK 465 GLU C 224 REMARK 465 VAL C 225 REMARK 465 VAL C 226 REMARK 465 TRP C 227 REMARK 465 PRO C 228 REMARK 465 GLY C 229 REMARK 465 VAL C 230 REMARK 465 THR C 231 REMARK 465 SER C 232 REMARK 465 MET C 233 REMARK 465 PRO C 234 REMARK 465 ASP C 235 REMARK 465 TYR C 236 REMARK 465 LYS C 237 REMARK 465 PRO C 238 REMARK 465 SER C 239 REMARK 465 PHE C 240 REMARK 465 PRO C 241 REMARK 465 LYS C 242 REMARK 465 TRP C 243 REMARK 465 ALA C 244 REMARK 465 ARG C 245 REMARK 465 GLN C 246 REMARK 465 ASP C 247 REMARK 465 ARG C 297 REMARK 465 LEU C 298 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PRO A -3 CB CG CD REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2097 O HOH B 2009 1.73 REMARK 500 SG CYS A 177 CE MET A 233 1.91 REMARK 500 OG1 THR A 72 O HOH A 2037 2.00 REMARK 500 O GLN A 246 O HOH A 2111 2.05 REMARK 500 NH1 ARG A 22 O HOH A 2009 2.12 REMARK 500 O PHE A 248 O HOH A 2130 2.18 REMARK 500 O LEU B 432 O HOH B 2131 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 2153 O HOH C 2099 3454 1.84 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 51 CD GLU A 51 OE2 0.137 REMARK 500 GLU A 162 C GLU A 162 O 0.118 REMARK 500 ASP A 256 CB ASP A 256 CG 0.132 REMARK 500 GLU B 188 CD GLU B 188 OE1 0.072 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 217 NE - CZ - NH1 ANGL. DEV. = 4.0 DEGREES REMARK 500 ARG A 217 NE - CZ - NH2 ANGL. DEV. = -5.7 DEGREES REMARK 500 ASP A 223 CB - CG - OD1 ANGL. DEV. = 6.1 DEGREES REMARK 500 ASP A 247 CB - CG - OD1 ANGL. DEV. = 5.8 DEGREES REMARK 500 ARG B 241 NE - CZ - NH2 ANGL. DEV. = -3.4 DEGREES REMARK 500 MET B 334 CG - SD - CE ANGL. DEV. = -16.6 DEGREES REMARK 500 ARG C 199 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 ARG C 199 NE - CZ - NH2 ANGL. DEV. = -4.0 DEGREES REMARK 500 VAL D 175 N - CA - C ANGL. DEV. = -21.4 DEGREES REMARK 500 ARG D 241 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 ARG D 250 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A -2 63.29 -51.24 REMARK 500 SER A 0 -143.22 -154.88 REMARK 500 MET A 1 -42.27 126.30 REMARK 500 LEU A 96 -57.61 86.06 REMARK 500 ASP A 127 41.46 -156.31 REMARK 500 ASP A 145 77.88 46.96 REMARK 500 GLU A 162 -78.36 -15.18 REMARK 500 VAL A 164 130.01 80.99 REMARK 500 SER A 181 -159.74 -141.18 REMARK 500 VAL B 175 67.32 28.13 REMARK 500 ASP B 284 28.99 48.06 REMARK 500 PHE B 304 17.18 58.75 REMARK 500 TRP B 372 108.33 -35.08 REMARK 500 SER C 0 -168.41 -50.88 REMARK 500 SER C 0 -162.73 -60.92 REMARK 500 THR C 14 58.36 -105.34 REMARK 500 TYR C 15 -65.43 -153.79 REMARK 500 THR C 41 -94.86 -138.66 REMARK 500 ASP C 127 45.10 -155.42 REMARK 500 ASP C 145 77.67 45.07 REMARK 500 VAL C 164 126.58 73.42 REMARK 500 HIS C 295 85.08 -67.74 REMARK 500 ASN D 173 -5.77 -57.71 REMARK 500 GLU D 174 48.33 -146.96 REMARK 500 ASP D 283 -138.58 59.91 REMARK 500 TRP D 372 112.75 -32.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLU A 162 VAL A 163 -44.79 REMARK 500 GLY C -1 SER C 0 -148.30 REMARK 500 GLU D 174 VAL D 175 -40.64 REMARK 500 ASP D 284 THR D 285 -149.22 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH D2009 DISTANCE = 6.72 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A1300 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 PRO A 271 O REMARK 620 2 ARG A 274 O 104.4 REMARK 620 3 HOH A2143 O 109.8 74.2 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG D1433 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 MET D 200 O REMARK 620 2 GLN D 203 O 90.1 REMARK 620 3 ILE D 206 O 104.6 91.4 REMARK 620 4 HOH D2021 O 87.1 173.7 94.8 REMARK 620 5 HOH D2024 O 175.1 89.2 80.3 93.0 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2WC A 1299 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2WC C 1297 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 1300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG D 1433 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4CFM RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6- REMARK 900 CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS. REMARK 900 RELATED ID: 4CFN RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6- REMARK 900 CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS. REMARK 900 RELATED ID: 4CFV RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6- REMARK 900 CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS. REMARK 900 RELATED ID: 4CFW RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6- REMARK 900 CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS. REMARK 900 RELATED ID: 4CFX RELATED DB: PDB REMARK 900 STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6- REMARK 900 CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS. REMARK 999 REMARK 999 SEQUENCE REMARK 999 N-TERMINAL 3C PROTEASE SITE. SEQUENCE OF CHAINS B AND D REMARK 999 UNCONFIRMED DBREF 4CFU A 1 298 UNP P24941 CDK2_HUMAN 1 298 DBREF 4CFU B 172 432 UNP P20248 CCNA2_HUMAN 172 432 DBREF 4CFU C 1 298 UNP P24941 CDK2_HUMAN 1 298 DBREF 4CFU D 173 432 UNP P20248 CCNA2_HUMAN 173 432 SEQADV 4CFU GLY A -4 UNP P24941 EXPRESSION TAG SEQADV 4CFU PRO A -3 UNP P24941 EXPRESSION TAG SEQADV 4CFU PRO A -2 UNP P24941 EXPRESSION TAG SEQADV 4CFU GLY A -1 UNP P24941 EXPRESSION TAG SEQADV 4CFU SER A 0 UNP P24941 EXPRESSION TAG SEQADV 4CFU GLY B 171 UNP P20248 EXPRESSION TAG SEQADV 4CFU ALA B 303 UNP P20248 THR 303 CONFLICT SEQADV 4CFU ILE B 311 UNP P20248 VAL 311 CONFLICT SEQADV 4CFU ALA B 357 UNP P20248 GLY 357 CONFLICT SEQADV 4CFU VAL B 377 UNP P20248 ILE 377 CONFLICT SEQADV 4CFU GLN B 378 UNP P20248 ARG 378 CONFLICT SEQADV 4CFU THR B 386 UNP P20248 SER 386 CONFLICT SEQADV 4CFU LEU B 392 UNP P20248 MET 392 CONFLICT SEQADV 4CFU ARG B 400 UNP P20248 LYS 400 CONFLICT SEQADV 4CFU GLY C -4 UNP P24941 EXPRESSION TAG SEQADV 4CFU PRO C -3 UNP P24941 EXPRESSION TAG SEQADV 4CFU PRO C -2 UNP P24941 EXPRESSION TAG SEQADV 4CFU GLY C -1 UNP P24941 EXPRESSION TAG SEQADV 4CFU SER C 0 UNP P24941 EXPRESSION TAG SEQADV 4CFU ASN D 171 UNP P20248 EXPRESSION TAG SEQADV 4CFU GLU D 172 UNP P20248 EXPRESSION TAG SEQADV 4CFU ALA D 303 UNP P20248 THR 303 CONFLICT SEQADV 4CFU ILE D 311 UNP P20248 VAL 311 CONFLICT SEQADV 4CFU ALA D 357 UNP P20248 GLY 357 CONFLICT SEQADV 4CFU VAL D 377 UNP P20248 ILE 377 CONFLICT SEQADV 4CFU GLN D 378 UNP P20248 ARG 378 CONFLICT SEQADV 4CFU THR D 386 UNP P20248 SER 386 CONFLICT SEQADV 4CFU LEU D 392 UNP P20248 MET 392 CONFLICT SEQADV 4CFU ARG D 400 UNP P20248 LYS 400 CONFLICT SEQRES 1 A 303 GLY PRO PRO GLY SER MET GLU ASN PHE GLN LYS VAL GLU SEQRES 2 A 303 LYS ILE GLY GLU GLY THR TYR GLY VAL VAL TYR LYS ALA SEQRES 3 A 303 ARG ASN LYS LEU THR GLY GLU VAL VAL ALA LEU LYS LYS SEQRES 4 A 303 ILE ARG LEU ASP THR GLU THR GLU GLY VAL PRO SER THR SEQRES 5 A 303 ALA ILE ARG GLU ILE SER LEU LEU LYS GLU LEU ASN HIS SEQRES 6 A 303 PRO ASN ILE VAL LYS LEU LEU ASP VAL ILE HIS THR GLU SEQRES 7 A 303 ASN LYS LEU TYR LEU VAL PHE GLU PHE LEU HIS GLN ASP SEQRES 8 A 303 LEU LYS LYS PHE MET ASP ALA SER ALA LEU THR GLY ILE SEQRES 9 A 303 PRO LEU PRO LEU ILE LYS SER TYR LEU PHE GLN LEU LEU SEQRES 10 A 303 GLN GLY LEU ALA PHE CYS HIS SER HIS ARG VAL LEU HIS SEQRES 11 A 303 ARG ASP LEU LYS PRO GLN ASN LEU LEU ILE ASN THR GLU SEQRES 12 A 303 GLY ALA ILE LYS LEU ALA ASP PHE GLY LEU ALA ARG ALA SEQRES 13 A 303 PHE GLY VAL PRO VAL ARG THR TYR TPO HIS GLU VAL VAL SEQRES 14 A 303 THR LEU TRP TYR ARG ALA PRO GLU ILE LEU LEU GLY CYS SEQRES 15 A 303 LYS TYR TYR SER THR ALA VAL ASP ILE TRP SER LEU GLY SEQRES 16 A 303 CYS ILE PHE ALA GLU MET VAL THR ARG ARG ALA LEU PHE SEQRES 17 A 303 PRO GLY ASP SER GLU ILE ASP GLN LEU PHE ARG ILE PHE SEQRES 18 A 303 ARG THR LEU GLY THR PRO ASP GLU VAL VAL TRP PRO GLY SEQRES 19 A 303 VAL THR SER MET PRO ASP TYR LYS PRO SER PHE PRO LYS SEQRES 20 A 303 TRP ALA ARG GLN ASP PHE SER LYS VAL VAL PRO PRO LEU SEQRES 21 A 303 ASP GLU ASP GLY ARG SER LEU LEU SER GLN MET LEU HIS SEQRES 22 A 303 TYR ASP PRO ASN LYS ARG ILE SER ALA LYS ALA ALA LEU SEQRES 23 A 303 ALA HIS PRO PHE PHE GLN ASP VAL THR LYS PRO VAL PRO SEQRES 24 A 303 HIS LEU ARG LEU SEQRES 1 B 262 GLY VAL ASN GLU VAL PRO ASP TYR HIS GLU ASP ILE HIS SEQRES 2 B 262 THR TYR LEU ARG GLU MET GLU VAL LYS CYS LYS PRO LYS SEQRES 3 B 262 VAL GLY TYR MET LYS LYS GLN PRO ASP ILE THR ASN SER SEQRES 4 B 262 MET ARG ALA ILE LEU VAL ASP TRP LEU VAL GLU VAL GLY SEQRES 5 B 262 GLU GLU TYR LYS LEU GLN ASN GLU THR LEU HIS LEU ALA SEQRES 6 B 262 VAL ASN TYR ILE ASP ARG PHE LEU SER SER MET SER VAL SEQRES 7 B 262 LEU ARG GLY LYS LEU GLN LEU VAL GLY THR ALA ALA MET SEQRES 8 B 262 LEU LEU ALA SER LYS PHE GLU GLU ILE TYR PRO PRO GLU SEQRES 9 B 262 VAL ALA GLU PHE VAL TYR ILE THR ASP ASP THR TYR THR SEQRES 10 B 262 LYS LYS GLN VAL LEU ARG MET GLU HIS LEU VAL LEU LYS SEQRES 11 B 262 VAL LEU ALA PHE ASP LEU ALA ALA PRO THR ILE ASN GLN SEQRES 12 B 262 PHE LEU THR GLN TYR PHE LEU HIS GLN GLN PRO ALA ASN SEQRES 13 B 262 CYS LYS VAL GLU SER LEU ALA MET PHE LEU GLY GLU LEU SEQRES 14 B 262 SER LEU ILE ASP ALA ASP PRO TYR LEU LYS TYR LEU PRO SEQRES 15 B 262 SER VAL ILE ALA ALA ALA ALA PHE HIS LEU ALA LEU TYR SEQRES 16 B 262 THR VAL THR GLY GLN SER TRP PRO GLU SER LEU VAL GLN SEQRES 17 B 262 LYS THR GLY TYR THR LEU GLU THR LEU LYS PRO CYS LEU SEQRES 18 B 262 LEU ASP LEU HIS GLN THR TYR LEU ARG ALA PRO GLN HIS SEQRES 19 B 262 ALA GLN GLN SER ILE ARG GLU LYS TYR LYS ASN SER LYS SEQRES 20 B 262 TYR HIS GLY VAL SER LEU LEU ASN PRO PRO GLU THR LEU SEQRES 21 B 262 ASN LEU SEQRES 1 C 303 GLY PRO PRO GLY SER MET GLU ASN PHE GLN LYS VAL GLU SEQRES 2 C 303 LYS ILE GLY GLU GLY THR TYR GLY VAL VAL TYR LYS ALA SEQRES 3 C 303 ARG ASN LYS LEU THR GLY GLU VAL VAL ALA LEU LYS LYS SEQRES 4 C 303 ILE ARG LEU ASP THR GLU THR GLU GLY VAL PRO SER THR SEQRES 5 C 303 ALA ILE ARG GLU ILE SER LEU LEU LYS GLU LEU ASN HIS SEQRES 6 C 303 PRO ASN ILE VAL LYS LEU LEU ASP VAL ILE HIS THR GLU SEQRES 7 C 303 ASN LYS LEU TYR LEU VAL PHE GLU PHE LEU HIS GLN ASP SEQRES 8 C 303 LEU LYS LYS PHE MET ASP ALA SER ALA LEU THR GLY ILE SEQRES 9 C 303 PRO LEU PRO LEU ILE LYS SER TYR LEU PHE GLN LEU LEU SEQRES 10 C 303 GLN GLY LEU ALA PHE CYS HIS SER HIS ARG VAL LEU HIS SEQRES 11 C 303 ARG ASP LEU LYS PRO GLN ASN LEU LEU ILE ASN THR GLU SEQRES 12 C 303 GLY ALA ILE LYS LEU ALA ASP PHE GLY LEU ALA ARG ALA SEQRES 13 C 303 PHE GLY VAL PRO VAL ARG THR TYR TPO HIS GLU VAL VAL SEQRES 14 C 303 THR LEU TRP TYR ARG ALA PRO GLU ILE LEU LEU GLY CYS SEQRES 15 C 303 LYS TYR TYR SER THR ALA VAL ASP ILE TRP SER LEU GLY SEQRES 16 C 303 CYS ILE PHE ALA GLU MET VAL THR ARG ARG ALA LEU PHE SEQRES 17 C 303 PRO GLY ASP SER GLU ILE ASP GLN LEU PHE ARG ILE PHE SEQRES 18 C 303 ARG THR LEU GLY THR PRO ASP GLU VAL VAL TRP PRO GLY SEQRES 19 C 303 VAL THR SER MET PRO ASP TYR LYS PRO SER PHE PRO LYS SEQRES 20 C 303 TRP ALA ARG GLN ASP PHE SER LYS VAL VAL PRO PRO LEU SEQRES 21 C 303 ASP GLU ASP GLY ARG SER LEU LEU SER GLN MET LEU HIS SEQRES 22 C 303 TYR ASP PRO ASN LYS ARG ILE SER ALA LYS ALA ALA LEU SEQRES 23 C 303 ALA HIS PRO PHE PHE GLN ASP VAL THR LYS PRO VAL PRO SEQRES 24 C 303 HIS LEU ARG LEU SEQRES 1 D 262 ASN GLU ASN GLU VAL PRO ASP TYR HIS GLU ASP ILE HIS SEQRES 2 D 262 THR TYR LEU ARG GLU MET GLU VAL LYS CYS LYS PRO LYS SEQRES 3 D 262 VAL GLY TYR MET LYS LYS GLN PRO ASP ILE THR ASN SER SEQRES 4 D 262 MET ARG ALA ILE LEU VAL ASP TRP LEU VAL GLU VAL GLY SEQRES 5 D 262 GLU GLU TYR LYS LEU GLN ASN GLU THR LEU HIS LEU ALA SEQRES 6 D 262 VAL ASN TYR ILE ASP ARG PHE LEU SER SER MET SER VAL SEQRES 7 D 262 LEU ARG GLY LYS LEU GLN LEU VAL GLY THR ALA ALA MET SEQRES 8 D 262 LEU LEU ALA SER LYS PHE GLU GLU ILE TYR PRO PRO GLU SEQRES 9 D 262 VAL ALA GLU PHE VAL TYR ILE THR ASP ASP THR TYR THR SEQRES 10 D 262 LYS LYS GLN VAL LEU ARG MET GLU HIS LEU VAL LEU LYS SEQRES 11 D 262 VAL LEU ALA PHE ASP LEU ALA ALA PRO THR ILE ASN GLN SEQRES 12 D 262 PHE LEU THR GLN TYR PHE LEU HIS GLN GLN PRO ALA ASN SEQRES 13 D 262 CYS LYS VAL GLU SER LEU ALA MET PHE LEU GLY GLU LEU SEQRES 14 D 262 SER LEU ILE ASP ALA ASP PRO TYR LEU LYS TYR LEU PRO SEQRES 15 D 262 SER VAL ILE ALA ALA ALA ALA PHE HIS LEU ALA LEU TYR SEQRES 16 D 262 THR VAL THR GLY GLN SER TRP PRO GLU SER LEU VAL GLN SEQRES 17 D 262 LYS THR GLY TYR THR LEU GLU THR LEU LYS PRO CYS LEU SEQRES 18 D 262 LEU ASP LEU HIS GLN THR TYR LEU ARG ALA PRO GLN HIS SEQRES 19 D 262 ALA GLN GLN SER ILE ARG GLU LYS TYR LYS ASN SER LYS SEQRES 20 D 262 TYR HIS GLY VAL SER LEU LEU ASN PRO PRO GLU THR LEU SEQRES 21 D 262 ASN LEU MODRES 4CFU TPO A 160 THR PHOSPHOTHREONINE MODRES 4CFU TPO C 160 THR PHOSPHOTHREONINE HET TPO A 160 11 HET TPO C 160 11 HET 2WC A1299 28 HET MG A1300 1 HET 2WC C1297 28 HET MG D1433 1 HETNAM TPO PHOSPHOTHREONINE HETNAM 2WC 3-[2-AZANYL-6-(CYCLOHEXYLMETHOXY)-7H-PURIN-8-YL]-2- HETNAM 2 2WC METHYL-BENZOIC ACID HETNAM MG MAGNESIUM ION HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 5 2WC 2(C20 H23 N5 O3) FORMUL 6 MG 2(MG 2+) FORMUL 9 HOH *489(H2 O) HELIX 1 1 PRO A 45 LEU A 58 1 14 HELIX 2 2 LEU A 87 SER A 94 1 8 HELIX 3 3 PRO A 100 HIS A 121 1 22 HELIX 4 4 LYS A 129 GLN A 131 5 3 HELIX 5 5 THR A 165 ARG A 169 5 5 HELIX 6 6 ALA A 170 LEU A 175 1 6 HELIX 7 7 THR A 182 ARG A 199 1 18 HELIX 8 8 SER A 207 GLY A 220 1 14 HELIX 9 9 GLY A 229 MET A 233 5 5 HELIX 10 10 ASP A 256 LEU A 267 1 12 HELIX 11 11 SER A 276 LEU A 281 1 6 HELIX 12 12 ALA A 282 VAL A 289 5 8 HELIX 13 13 GLY B 171 VAL B 175 5 5 HELIX 14 14 TYR B 178 CYS B 193 1 16 HELIX 15 15 GLY B 198 GLN B 203 5 6 HELIX 16 16 THR B 207 TYR B 225 1 19 HELIX 17 17 GLN B 228 SER B 244 1 17 HELIX 18 18 LEU B 249 GLY B 251 5 3 HELIX 19 19 LYS B 252 GLU B 269 1 18 HELIX 20 20 GLU B 274 THR B 282 1 9 HELIX 21 21 THR B 287 LEU B 302 1 16 HELIX 22 22 THR B 310 LEU B 320 1 11 HELIX 23 23 ASN B 326 ASP B 343 1 18 HELIX 24 24 ASP B 343 LEU B 348 1 6 HELIX 25 25 LEU B 351 GLY B 369 1 19 HELIX 26 26 PRO B 373 GLY B 381 1 9 HELIX 27 27 THR B 383 ALA B 401 1 19 HELIX 28 28 PRO B 402 HIS B 404 5 3 HELIX 29 29 GLN B 407 TYR B 413 1 7 HELIX 30 30 LYS B 414 HIS B 419 5 6 HELIX 31 31 GLY B 420 LEU B 424 5 5 HELIX 32 32 PRO C 45 LEU C 58 1 14 HELIX 33 33 LEU C 87 SER C 94 1 8 HELIX 34 34 PRO C 100 HIS C 121 1 22 HELIX 35 35 LYS C 129 GLN C 131 5 3 HELIX 36 36 ASP C 145 ALA C 149 5 5 HELIX 37 37 THR C 165 ARG C 169 5 5 HELIX 38 38 ALA C 170 LEU C 175 1 6 HELIX 39 39 THR C 182 ARG C 199 1 18 HELIX 40 40 SER C 207 GLY C 220 1 14 HELIX 41 41 ASP C 256 LEU C 267 1 12 HELIX 42 42 SER C 276 ALA C 282 1 7 HELIX 43 43 HIS C 283 GLN C 287 5 5 HELIX 44 44 ASN D 171 VAL D 175 5 5 HELIX 45 45 TYR D 178 CYS D 193 1 16 HELIX 46 46 TYR D 199 GLN D 203 5 5 HELIX 47 47 THR D 207 TYR D 225 1 19 HELIX 48 48 GLN D 228 SER D 244 1 17 HELIX 49 49 LEU D 249 GLY D 251 5 3 HELIX 50 50 LYS D 252 GLU D 269 1 18 HELIX 51 51 GLU D 274 THR D 282 1 9 HELIX 52 52 THR D 287 LEU D 302 1 16 HELIX 53 53 THR D 310 LEU D 320 1 11 HELIX 54 54 ASN D 326 ASP D 343 1 18 HELIX 55 55 ASP D 343 LEU D 348 1 6 HELIX 56 56 LEU D 351 GLY D 369 1 19 HELIX 57 57 PRO D 373 GLY D 381 1 9 HELIX 58 58 THR D 383 ALA D 401 1 19 HELIX 59 59 PRO D 402 HIS D 404 5 3 HELIX 60 60 GLN D 407 TYR D 413 1 7 HELIX 61 61 LYS D 414 HIS D 419 5 6 HELIX 62 62 GLY D 420 LEU D 424 5 5 SHEET 1 AA 5 PHE A 4 GLU A 12 0 SHEET 2 AA 5 GLY A 16 ASN A 23 -1 O VAL A 18 N ILE A 10 SHEET 3 AA 5 VAL A 29 ARG A 36 -1 O VAL A 30 N ALA A 21 SHEET 4 AA 5 LYS A 75 GLU A 81 -1 O LEU A 76 N ILE A 35 SHEET 5 AA 5 LEU A 66 HIS A 71 -1 N LEU A 67 O VAL A 79 SHEET 1 AB 3 GLN A 85 ASP A 86 0 SHEET 2 AB 3 LEU A 133 ILE A 135 -1 O ILE A 135 N GLN A 85 SHEET 3 AB 3 ILE A 141 LEU A 143 -1 O LYS A 142 N LEU A 134 SHEET 1 AC 2 VAL A 123 LEU A 124 0 SHEET 2 AC 2 ARG A 150 ALA A 151 -1 O ARG A 150 N LEU A 124 SHEET 1 CA 5 PHE C 4 GLY C 11 0 SHEET 2 CA 5 GLY C 16 ASN C 23 -1 O VAL C 18 N ILE C 10 SHEET 3 CA 5 VAL C 29 ARG C 36 -1 O VAL C 30 N ALA C 21 SHEET 4 CA 5 LYS C 75 GLU C 81 -1 O LEU C 76 N ILE C 35 SHEET 5 CA 5 LEU C 66 HIS C 71 -1 N LEU C 67 O VAL C 79 SHEET 1 CB 3 GLN C 85 ASP C 86 0 SHEET 2 CB 3 LEU C 133 ILE C 135 -1 O ILE C 135 N GLN C 85 SHEET 3 CB 3 ILE C 141 LEU C 143 -1 O LYS C 142 N LEU C 134 SHEET 1 CC 2 VAL C 123 LEU C 124 0 SHEET 2 CC 2 ARG C 150 ALA C 151 -1 O ARG C 150 N LEU C 124 LINK C TYR A 159 N TPO A 160 1555 1555 1.33 LINK C TPO A 160 N HIS A 161 1555 1555 1.34 LINK C TYR C 159 N TPO C 160 1555 1555 1.34 LINK C TPO C 160 N HIS C 161 1555 1555 1.33 LINK O PRO A 271 MG MG A1300 1555 1555 2.68 LINK O ARG A 274 MG MG A1300 1555 1555 2.61 LINK MG MG A1300 O HOH A2143 1555 1555 2.74 LINK O MET D 200 MG MG D1433 1555 1555 2.56 LINK O GLN D 203 MG MG D1433 1555 1555 2.34 LINK O ILE D 206 MG MG D1433 1555 1555 2.52 LINK MG MG D1433 O HOH D2021 1555 1555 2.47 LINK MG MG D1433 O HOH D2024 1555 1555 2.44 CISPEP 1 GLY A -1 SER A 0 0 -2.58 CISPEP 2 THR A 14 TYR A 15 0 11.19 CISPEP 3 TYR A 15 GLY A 16 0 -0.08 CISPEP 4 VAL A 154 PRO A 155 0 -5.80 CISPEP 5 GLN B 323 PRO B 324 0 -12.09 CISPEP 6 ASP B 345 PRO B 346 0 6.87 CISPEP 7 PRO C -2 GLY C -1 0 -5.50 CISPEP 8 TYR C 15 GLY C 16 0 -11.45 CISPEP 9 VAL C 154 PRO C 155 0 -6.28 CISPEP 10 GLN D 323 PRO D 324 0 -4.13 CISPEP 11 ASP D 345 PRO D 346 0 5.22 SITE 1 AC1 15 ILE A 10 ALA A 31 VAL A 64 PHE A 80 SITE 2 AC1 15 GLU A 81 LEU A 83 HIS A 84 GLN A 85 SITE 3 AC1 15 ASP A 86 LYS A 89 GLN A 131 ASN A 132 SITE 4 AC1 15 LEU A 134 HOH A2007 HOH A2155 SITE 1 AC2 17 ILE C 10 ALA C 31 LYS C 33 VAL C 64 SITE 2 AC2 17 PHE C 80 GLU C 81 PHE C 82 LEU C 83 SITE 3 AC2 17 HIS C 84 GLN C 85 ASP C 86 LYS C 89 SITE 4 AC2 17 GLN C 131 ASN C 132 LEU C 134 HOH C2007 SITE 5 AC2 17 HOH C2112 SITE 1 AC3 4 PRO A 271 ARG A 274 HOH A2143 VAL B 172 SITE 1 AC4 5 MET D 200 GLN D 203 ILE D 206 HOH D2021 SITE 2 AC4 5 HOH D2024 CRYST1 73.806 133.744 147.460 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013549 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007477 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006782 0.00000